These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 12735989
1. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Ishikawa T, Matsunaga N, Tawada H, Kuroda N, Nakayama Y, Ishibashi Y, Tomimoto M, Ikeda Y, Tagawa Y, Iizawa Y, Okonogi K, Hashiguchi S, Miyake A. Bioorg Med Chem; 2003 May 29; 11(11):2427-37. PubMed ID: 12735989 [Abstract] [Full Text] [Related]
2. Studies on anti-MRSA parenteral cephalosporins. IV. A novel water-soluble N-phosphono type prodrug for parental administration. Ishikawa T, Nakayama Y, Tomimoto M, Niwa SI, Kamiyama K, Hashiguchi S, Iizawa Y, Okonogi K, Miyake A. J Antibiot (Tokyo); 2001 Apr 29; 54(4):364-74. PubMed ID: 11426661 [Abstract] [Full Text] [Related]
3. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Kamimura T, Tawara S, Matsumoto Y, Matsumoto F, Kuwahara S. J Antibiot (Tokyo); 1993 Jan 29; 46(1):99-119. PubMed ID: 8436564 [Abstract] [Full Text] [Related]
4. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Malouin F, Blais J, Chamberland S, Hoang M, Park C, Chan C, Mathias K, Hakem S, Dupree K, Liu E, Nguyen T, Dudley MN. Antimicrob Agents Chemother; 2003 Feb 29; 47(2):658-64. PubMed ID: 12543674 [Abstract] [Full Text] [Related]
5. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL. Antimicrob Agents Chemother; 2001 Mar 29; 45(3):825-36. PubMed ID: 11181368 [Abstract] [Full Text] [Related]
6. Novel cephalosporin derivatives possessing a bicyclic heterocycle at the 3-position. Part I: Synthesis and biological activities of 3-(benzothiazol-2-yl)thiocephalosporin derivatives, CP0467 and related compounds. Tsushima M, Iwamatsu K, Tamura A, Shibahara S. Bioorg Med Chem; 1998 Jul 29; 6(7):1009-17. PubMed ID: 9730237 [Abstract] [Full Text] [Related]
7. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2002 Jan 29; 46(1):171-7. PubMed ID: 11751129 [Abstract] [Full Text] [Related]
8. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. Piddock LJ, Traynor EA, Griggs DJ. Eur J Clin Microbiol Infect Dis; 1992 Apr 29; 11(4):364-71. PubMed ID: 1396760 [Abstract] [Full Text] [Related]
9. Stability and stabilization studies of TAK-599 (Ceftaroline Fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825. Ikeda Y, Ban J, Ishikawa T, Hashiguchi S, Urayama S, Horibe H. Chem Pharm Bull (Tokyo); 2008 Oct 29; 56(10):1406-11. PubMed ID: 18827379 [Abstract] [Full Text] [Related]
10. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli. Singh MP, Lee YI, Singh R, Micetich RG, Wilkinson BJ. J Antimicrob Chemother; 1991 Apr 29; 27(4):459-68. PubMed ID: 1856125 [Abstract] [Full Text] [Related]
11. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci. Fung-Tomc JC, Clark J, Minassian B, Pucci M, Tsai YH, Gradelski E, Lamb L, Medina I, Huczko E, Kolek B, Chaniewski S, Ferraro C, Washo T, Bonner DP. Antimicrob Agents Chemother; 2002 Apr 29; 46(4):971-6. PubMed ID: 11897577 [Abstract] [Full Text] [Related]
12. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Fujimura T, Yamano Y, Yoshida I, Shimada J, Kuwahara S. Antimicrob Agents Chemother; 2003 Mar 29; 47(3):923-31. PubMed ID: 12604523 [Abstract] [Full Text] [Related]
13. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins. Piddock LJ, Traynor EA, Wise R. J Antimicrob Chemother; 1989 Mar 29; 23 Suppl C():59-64. PubMed ID: 2732144 [Abstract] [Full Text] [Related]
14. Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureus. Hecker SJ, Cho IS, Glinka TW, Zhang ZJ, Price ME, Lee VJ, Christensen BG, Boggs A, Chamberland S, Malouin F, Parr TR, Annamalai T, Blais J, Bond EL, Case L, Chan C, Crase J, Frith R, Griffith D, Harford L, Liu N, Ludwikow M, Mathias K, Rea D, Williams R. J Antibiot (Tokyo); 1998 Aug 29; 51(8):722-34. PubMed ID: 9766464 [Abstract] [Full Text] [Related]
15. Novel dithiocarbamate carbapenems with anti-MRSA activity. Ohtake N, Imamura H, Jona H, Kiyonaga H, Shimizu A, Moriya M, Sato H, Nakano M, Ushijima R, Nakagawa S. Bioorg Med Chem; 1998 Jul 29; 6(7):1089-101. PubMed ID: 9730246 [Abstract] [Full Text] [Related]
16. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Que YA, Entenza JM, Francioli P, Moreillon P. J Infect Dis; 1998 Jan 29; 177(1):146-54. PubMed ID: 9419181 [Abstract] [Full Text] [Related]
17. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus]. Fukuoka T, Domon H, Kakuta M, Ishii C, Hirasawa A, Utsui Y, Ohya S, Yasuda H. Jpn J Antibiot; 1997 Apr 29; 50(4):411-9. PubMed ID: 9192249 [Abstract] [Full Text] [Related]
18. Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. Truesdell SE, Zurenko GE, Laborde AL. J Antimicrob Chemother; 1989 Apr 29; 23 Suppl D():13-9. PubMed ID: 2722720 [Abstract] [Full Text] [Related]
20. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci. Kurazono M, Ida T, Yamada K, Hirai Y, Maruyama T, Shitara E, Yonezawa M. Antimicrob Agents Chemother; 2004 Aug 29; 48(8):2831-7. PubMed ID: 15273088 [Abstract] [Full Text] [Related] Page: [Next] [New Search]